|
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), is a subtype of peripheral T-cell lymphoma. Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive lymphomas that develop from mature-stage white blood cells called T-cells and natural killer cells (NK cells) (see figure for an overview of PTCL subtypes). PTCL is a type of non-Hodgkin’s lymphoma (NHL).〔Swerdlow SH, ''WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues'', 2008〕 NHL affects two particular types of white blood cells: B-cells and T-cells. PTCL specifically affects T-cells, and results when T-cells develop and grow abnormally. File:PTCL-subtypes.jpg PTCL-NOS, the most common subtype of PTCL, is aggressive and predominantly nodal. There are two morphologic variants: the T-zone lymphoma variant and the lymphoepithelioid cell variant.〔O’Connor, Owen. Getting the Facts; Peripheral T-Cell Lymphoma. (version ) Retrieved May 19, 2009, from http://www.lymphoma.org/atf/cf/%7B0363CDD6-51B5-427B-BE48-E6AF871ACEC9%7D/PTCL.PDF〕 * T-zone lymphoma is so named for its involvement in a specific area of the lymph node that consists of a dense accumulation of T-cells. * Lympho-epithelioid lymphoma, also called Lennert's lymphoma, is rare and generally affects older individuals. ==Treatment== Currently PTCL is treated similarly to B-cell lymphomas. However, in recent years, scientists have developed techniques to better recognize the different types of lymphomas, such as PTCL. It is now understood that PTCL behaves differently from B-cell lymphomas and therapies are being developed that specifically target these types of lymphoma. Currently, however, there are no therapies approved by the US Food and Drug Administration (FDA) specifically for PTCL. Anthracycline-containing chemotherapy regimens are commonly offered as the initial therapy. Some patients may receive a stem cell transplant.〔d’Amore F, et al. ''Blood.'' 2006;108:A401〕 Novel approaches to the treatment of PTCL in the relapsed or refractory setting are under investigation. Pralatrexate is one compound currently under investigations for the treatment of PTCL. For information please consult the US clinical trials database ((http://www.clinicaltrials.gov )). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Peripheral T-cell lymphoma not otherwise specified」の詳細全文を読む スポンサード リンク
|
